47 related articles for article (PubMed ID: 38454378)
1. A challenging issue in COVID-19 infection: The relationship between PA1-1 and TAFI levels in patients with coagulation disorder: A retrospective and observational study.
Altin N; Tiğlioğlu P; Ulusoy TU; Aydin FN; Kar İ; Karakoc B; Utebey G
Medicine (Baltimore); 2024 Apr; 103(15):e37802. PubMed ID: 38608056
[TBL] [Abstract][Full Text] [Related]
2. Cancer-Associated Stroke: Thrombosis Mechanism, Diagnosis, Outcome, and Therapeutic Strategies.
Heo JH; Yun J; Kim KH; Jung JW; Yoo J; Kim YD; Nam HS
J Stroke; 2024 May; 26(2):164-178. PubMed ID: 38836266
[TBL] [Abstract][Full Text] [Related]
3. Insights into thrombin activatable fibrinolysis inhibitor function and regulation.
Foley JH; Kim PY; Mutch NJ; Gils A
J Thromb Haemost; 2013 Jun; 11 Suppl 1():306-15. PubMed ID: 23809134
[TBL] [Abstract][Full Text] [Related]
4. Thrombin-activatable fibrinolysis inhibitor.
Marx PF
Curr Med Chem; 2004 Sep; 11(17):2335-48. PubMed ID: 15379716
[TBL] [Abstract][Full Text] [Related]
5. High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states.
Agarwal T; Mereuta OM; Ghozy S; Larco JLA; Bilgin C; Kadirvel R; Brinjikji W; Kallmes DF
BMC Neurol; 2024 Mar; 24(1):90. PubMed ID: 38454378
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.
Jönsson Rylander AC; Lindgren A; Deinum J; Bergström GM; Böttcher G; Kalies I; Wåhlander K
J Thromb Haemost; 2017 Apr; 15(4):758-769. PubMed ID: 28135035
[TBL] [Abstract][Full Text] [Related]
7. Assessment of plasminogen activator inhibitor-1(PAI1) and thrombin activitable fibrinolysis inhibitor (TAFI) in Egyptian children with hemophilia A.
Soliman M; Osman N; Hefnawy S; El Hawy MA
Pediatr Hematol Oncol; 2022 May; 39(4):318-328. PubMed ID: 34668834
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between plasma levels of thrombin activatable fibrinolysis inhibitor, plasminogen activator inhibitor-1 and tissue-type plasminogen activator and deep venous thrombosis in patients with systemic lupus erythematosus].
Liu YF; Hou N; Shi YJ; Li CX; Gao YJ; Liu LN
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(21):1638-1642. PubMed ID: 37248064
[No Abstract] [Full Text] [Related]
9. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
Erem C; Nuhoglu I; Yilmaz M; Kocak M; Demirel A; Ucuncu O; Onder Ersoz H
J Endocrinol Invest; 2009 Feb; 32(2):169-74. PubMed ID: 19411818
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
Erem C; Nuhoglu I; Kocak M; Yilmaz M; Sipahi ST; Ucuncu O; Ersoz HO
Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
[TBL] [Abstract][Full Text] [Related]
11. Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system.
Suzuki Y; Sano H; Mochizuki L; Honkura N; Urano T
Blood Adv; 2020 Nov; 4(21):5501-5511. PubMed ID: 33166409
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and thrombosis: A bench to bedside review.
Abou-Ismail MY; Citla Sridhar D; Nayak L
Thromb Res; 2020 Aug; 192():40-51. PubMed ID: 32450447
[TBL] [Abstract][Full Text] [Related]
13. Orbit Image Analysis: An open-source whole slide image analysis tool.
Stritt M; Stalder AK; Vezzali E
PLoS Comput Biol; 2020 Feb; 16(2):e1007313. PubMed ID: 32023239
[TBL] [Abstract][Full Text] [Related]
14. Orbit image analysis machine learning software can be used for the histological quantification of acute ischemic stroke blood clots.
Fitzgerald S; Wang S; Dai D; Murphree DH; Pandit A; Douglas A; Rizvi A; Kadirvel R; Gilvarry M; McCarthy R; Stritt M; Gounis MJ; Brinjikji W; Kallmes DF; Doyle KM
PLoS One; 2019; 14(12):e0225841. PubMed ID: 31805096
[TBL] [Abstract][Full Text] [Related]
15. Effects of Estrogens on Platelets and Megakaryocytes.
Dupuis M; Severin S; Noirrit-Esclassan E; Arnal JF; Payrastre B; Valéra MC
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242705
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
